 |
市场调查报告书
商品编码
1671834
大肠激躁症治疗市场按类型、适应症、药物类别、给药途径、通路和地区划分Irritable Bowel Syndrome Treatment Market, By Type, By Indication, By Drug Class, By Route of Administration, By Distribution Channel, By Geography |
||||||
2025 年全球大肠激躁症治疗市场规模估计为 40.4 亿美元，预计到 2032 年将达到 74.3 亿美元，2025 年至 2032 年的复合年增长率为 9.1%。
| 报告范围 | 报告详细信息 | ||
|---|---|---|---|
| 基准年 | 2024 | 2025 年市场规模 | 40.4亿美元 |
| 效能资料 | 从 2020 年到 2024 年 | 预测期 | 2025 至 2032 年 |
| 预测期：2025-2032年复合年增长率： | 9.10% | 2032 年价值预测 | 74.3亿美元 |
大肠激躁症(IBS) 是一种影响大肠的常见功能性胃肠道疾病。肠躁症 (IBS) 会导致腹部痉挛、腹胀、胀气、腹泻和便秘。美国国家医学图书馆估计，到 2024 年 6 月，IBS 将影响全球约 11% 的人。肠躁症（IBS）的具体病因尚不清楚，但人们认为是由于消化道处理压力和调节正常功能和感觉的方式发生变化所致。由于肠躁症（IBS）盛行率不断上升以及对有效治疗方案的需求不断增加，全球大肠激躁症治疗市场在过去几年中一直保持稳定成长。
市场动态：
老年人口的不断增加推动了全球大肠激躁症治疗市场的发展，因为老年人更容易患上肠躁症。根据联合国的数据，到 2050 年，全球 60 岁及以上人口数量将从 2017 年的 9.62 亿增加到 21 亿。此外，对 IBS 的认识不断提高和诊断水平不断提高也支持了该市场的成长。然而，缺乏核准用于治疗 IBS 的药物、开发新疗法的成本高昂以及现有药物的副作用阻碍因素了市场的成长。新型药物配方和非药物替代品的开发可能为市场提供有利可图的机会。
本研究的主要特点
本报告对全球大肠激躁症治疗市场进行了详细分析，并以 2024 年为基准年，给出了预测期（2025-2032 年）的市场规模和年复合成长率（CAGR%）。
它还揭示了各个领域的潜在商机，并解释了该市场的有吸引力的投资提案矩阵。
它还提供了对市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景以及主要企业采用的竞争策略的重要见解。
全球大肠激躁症治疗市场的主要企业根据公司亮点、产品系列、关键亮点、绩效和策略等参数进行分析。
研究中介绍的主要企业包括 Ironwood Pharmaceuticals, Inc.、AbbVie Inc.、Astellas Pharma, Inc.、 工业 Company Limited、AstraZeneca Plc.、Sebela Pharmaceuticals, Inc.、Bausch Health Companies Inc.、Theriva Biologics, Inc.、Aroot, Inc. exicon Pharmaceuticals, Inc.、GSK plc 和 Johnson & Johnson Services, Inc.
本报告的见解将使负责人和企业经营团队能够就未来产品发布、高端市场策略、市场扩张和行销策略做出明智的决策。
全球大肠激躁症治疗市场报告涉及该行业的各个相关人员，例如投资者、供应商、产品製造商、经销商、新进入者和金融分析师。
目录
第一章 调查目的与前提条件
- 研究目标
- 先决条件
- 简称
第二章 市场展望
- 报告描述
- 市场定义和范围
- 执行摘要
第三章市场动态、法规与趋势分析
- 市场动态
- 影响分析
- 主要进展
- 监管情景
- 产品发布/核准
- PEST分析
- PORTER 分析
- 併购情景
- 产业趋势
第 4 章 全球大肠激躁症治疗市场（按类型），2020 年至 2032 年
- 伴随便秘的大肠激躁症(IBS-C)
- 腹泻大肠激躁症(IBS-D)
- 混合型大肠激躁症（IBS-M）
第 5 章 全球大肠激躁症治疗市场（依适应症划分），2020 年至 2032 年
- 腹痛
- 腹胀
- 便秘和腹泻
- 排便习惯改变
- 其他的
第 6 章 2020 年至 2032 年按药物类别分類的全球大肠激躁症治疗市场
- 解痉药
- 泻药
- 止泻药
- 5-HT3 受体拮抗剂
- 鸟粪嘌呤环化酶致效剂
- 抗胆碱能药物
- 益生菌
- 抗忧郁症
- 抗生素
- 营养补充品
- 其他的
第 7 章 全球大肠激躁症治疗市场，依给药途径，2020 年至 2032 年
- 口服
- 直肠
- 肠外
第 8 章 全球大肠激躁症治疗市场依通路划分，2020 年至 2032 年
- 医院药房
- 零售药局
- 网路药局
第 9 章 全球大肠激躁症治疗市场（按地区划分），2020 年至 2032 年
- 北美洲
- 拉丁美洲
- 欧洲
- 亚太地区
- 中东
- 非洲
第十章 竞争格局
- Ironwood Pharmaceuticals, Inc.
- AbbVie Inc.
- Astellas Pharma, Inc.
- Takeda Pharmaceutical Company Limited
- AstraZeneca Plc.
- Sebela Pharmaceuticals, Inc.
- Bausch Health Companies Inc.
- Theriva Biologics, Inc.
- Ardelyx, Inc.
- Salix Pharmaceuticals, Inc.
- Mallinckrodt Pharmaceuticals
- Abbott Laboratories
- Lexicon Pharmaceuticals, Inc.
- GSK plc
- Johnson & Johnson Services, Inc.
第 11 章 分析师建议
- 命运之轮
- 分析师观点
- 一致的机会图
第 12 章参考文献与调查方法
- 参考
- 调查方法
- 关于出版商
Global Irritable Bowel Syndrome Treatment Market is estimated to be valued at US$ 4.04 Bn in 2025 and is expected to reach US$ 7.43 Bn by 2032, growing at a compound annual growth rate (CAGR) of 9.1% from 2025 to 2032.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2024 | Market Size in 2025: | US$ 4.04 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: | 9.10% | 2032 Value Projection: | US$ 7.43 Bn |
Irritable bowel syndrome (IBS) is a common functional gastrointestinal disorder that affects the large intestine. IBS causes abdominal cramping, bloating, gas, and diarrhea and/or constipation. As per National Library of Medicine estimates, in June 2024, IBS affects around 11% of people worldwide. The exact causes of IBS are unknown, but it is believed to be due to changes in the way the gastrointestinal tract handles stress and regulates normal function and sensations. The global irritable bowel syndrome treatment market has been witnessing steady growth over the past few years owing to the increasing prevalence of IBS and growing demand for effective treatment options.
Market Dynamics:
The global irritable bowel syndrome treatment market is driven by the rising geriatric population, as seniors are more prone to develop IBS. According to the United Nations, the number of people aged 60 or above will increase from 962 million globally in 2017 to 2.1 billion in 2050. Moreover, growing awareness and better diagnosis of IBS are also supporting the growth of this market. However, the lack of approved drugs for IBS, high development costs of new therapies, and side effects associated with existing drugs are some of the key factors are hampering the market growth. The development of novel drug formulations and non-drug treatment alternatives can present lucrative opportunities in the market.
Key Features of the Study:
This report provides in-depth analysis of the global irritable bowel syndrome treatment market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global irritable bowel syndrome treatment market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Ironwood Pharmaceuticals, Inc., AbbVie Inc., Astellas Pharma, Inc., Takeda Pharmaceutical Company Limited, AstraZeneca Plc., Sebela Pharmaceuticals, Inc., Bausch Health Companies Inc., Theriva Biologics, Inc., Ardelyx, Inc., Salix Pharmaceuticals, Inc., Mallinckrodt Pharmaceuticals, Abbott Laboratories, Lexicon Pharmaceuticals, Inc., GSK plc, and Johnson & Johnson Services, Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global irritable bowel syndrome treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Market Segmentation
- By Type Insights (Revenue, USD Bn, 2020 - 2032)
- Irritable Bowel Syndrome with Constipation (IBS-C)
- Irritable Bowel Syndrome with Diarrhea (IBS-D)
- Mixed Irritable Bowel Syndrome (IBS-M)
- By Indication Insights (Revenue, USD Bn, 2020 - 2032)
- Abdominal Pain
- Bloating
- Constipation and Diarrhea
- Altered Bowel Habits
- Others
- By Drug Class Insights (Revenue, USD Bn, 2020 - 2032)
- Antispasmodics
- Laxatives
- Antidiarrheal Medications
- 5-HT3 Receptor Antagonists
- Guanylate Cyclase-C Agonists
- Anticholinergic
- Probiotics
- Antidepressants
- Antibiotics
- Dietary Supplements
- Others
- By Route of Administration Insights (Revenue, USD Bn, 2020 - 2032)
- Oral
- Rectal
- Parenteral
- By Distribution Channel Insights (Revenue, USD Bn, 2020 - 2032)
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- Regional Insights (Revenue, USD Bn, 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Ironwood Pharmaceuticals, Inc.
- AbbVie Inc.
- Astellas Pharma, Inc.
- Takeda Pharmaceutical Company Limited
- AstraZeneca Plc.
- Sebela Pharmaceuticals, Inc.
- Bausch Health Companies Inc.
- Theriva Biologics, Inc.
- Ardelyx, Inc.
- Salix Pharmaceuticals, Inc.
- Mallinckrodt Pharmaceuticals
- Abbott Laboratories
- Lexicon Pharmaceuticals, Inc.
- GSK plc
- Johnson & Johnson Services, Inc.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Irritable Bowel Syndrome Treatment Market, By Type
- Global Irritable Bowel Syndrome Treatment Market, By Indication
- Global Irritable Bowel Syndrome Treatment Market, By Drug Class
- Global Irritable Bowel Syndrome Treatment Market, By Route of Administration
- Global Irritable Bowel Syndrome Treatment Market, By Distribution Channel
- Global Irritable Bowel Syndrome Treatment Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Industry Trends
4. Global Irritable Bowel Syndrome Treatment Market, By Type, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Irritable Bowel Syndrome with Constipation (IBS-C)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Irritable Bowel Syndrome with Diarrhea (IBS-D)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Mixed Irritable Bowel Syndrome (IBS-M)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
5. Global Irritable Bowel Syndrome Treatment Market, By Indication, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Abdominal Pain
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Bloating
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Constipation and Diarrhea
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Altered Bowel Habits
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
6. Global Irritable Bowel Syndrome Treatment Market, By Drug Class, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Antispasmodics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Laxatives
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Antidiarrheal Medications
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- 5-HT3 Receptor Antagonists
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Guanylate Cyclase-C Agonists
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Anticholinergic
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Probiotics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Antidepressants
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Antibiotics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Dietary Supplements
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
7. Global Irritable Bowel Syndrome Treatment Market, By Route of Administration, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Rectal
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Parenteral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
8. Global Irritable Bowel Syndrome Treatment Market, By Distribution Channel, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Hospital Pharmacy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Retail Pharmacy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Online Pharmacy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
9. Global Irritable Bowel Syndrome Treatment Market, By Region, 2020 - 2032, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Drug Class, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Drug Class, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Drug Class, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Drug Class, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Drug Class, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Drug Class, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
10. Competitive Landscape
- Ironwood Pharmaceuticals, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- AbbVie Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Astellas Pharma, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Takeda Pharmaceutical Company Limited
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- AstraZeneca Plc.
- Sebela Pharmaceuticals, Inc.
- Bausch Health Companies Inc.
- Theriva Biologics, Inc.
- Ardelyx, Inc.
- Salix Pharmaceuticals, Inc.
- Mallinckrodt Pharmaceuticals
- Abbott Laboratories
- Lexicon Pharmaceuticals, Inc.
- GSK plc
- Johnson & Johnson Services, Inc.
11. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
12. References and Research Methodology
- References
- Research Methodology
- About us
全球发炎性肠道疾病治疗市场研究报告-产业分析、规模、份额、成长、趋势和预测 2025 年至 2033 年
粪钙卫蛋白检测市场规模、份额、趋势分析报告：按分析、最终用途、地区和细分市场预测，2025-2030 年
发炎性肠道疾病药物市场：按类型、药物类别、给药途径、分销管道 - 2025-2030 年全球预测
非诺贝林市场：按产品类型、应用和最终用途 - 全球预测 2025-2030
全球发炎性肠道疾病（IBD）市场评估：按类型、药物类别、给药途径、分布、地区、机会、预测（2017-2031）
大肠激躁症治疗市场规模、份额、分析报告：2025-2030 年按类型、产品、分销管道、地区和细分市场预测
2024-2032 年肠躁症治疗市场报告（依类型（腹泻型肠躁症、便秘型肠躁症、混合型肠躁症）、产品、配销通路及地区
粪钙卫蛋白测试市场 - 全球产业规模、份额、趋势、机会和预测，按检测类型、适应症、最终用户、地区和竞争细分，2019-2029F
发炎性肠道疾病治疗市场、机会、成长动力、产业趋势分析与预测，2024-2032
发炎性肠道疾病疾病治疗的市场规模、份额和趋势分析报告：按类型、药物类别、给药途径、通路、地区、细分市场预测，2024-2030年